A simple method to purify recombinant HCV core protein expressed in Pichia pastoris for obtaining virus-like particles and producing monoclonal antibodies

被引:5
作者
Pechelyulko, Anastasia [1 ]
Andreeva-Kovalevskaya, Zhanna [2 ]
Dmitriev, Dmitriy [1 ]
Lavrov, Viacheslav [1 ]
Massino, Yulia [1 ]
Nagel, Alexey [2 ]
Segal, Olga [1 ]
Sokolova, Olga S. [3 ]
Solonin, Alexander [2 ]
Tarakanova, Yulia [1 ]
Dmitriev, Alexander [1 ]
机构
[1] Mechnikov Sci Res Inst Vaccines & Sera, 5A Maly Kazenny Lane, Moscow 105064, Russia
[2] Russian Acad Sci, FSBIS GK Skryabin Inst Biochem & Physiol Microorg, Pushchino, Moscow Region, Russia
[3] Lomonosov Moscow State Univ, Fac Biol, Dept Bioengn, Moscow 119991, Russia
关键词
Hepatitis C; HCcAg; Virus-like particle; Pichia pastoris; Core antigen; Monoclonal antibody; HEPATITIS-C VIRUS; ANTIGEN; CELLS;
D O I
10.1016/j.pep.2021.105864
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we describe an optimized method of obtaining virus-like particles (VLPs) of the recombinant hepatitis C virus (HCV) core protein (HCcAg) expressed in yeast cells (Pichia pastoris), which can be used for the construction of diagnostic test systems and vaccine engineering. The described simplified procedure was developed to enable in vitro self-assembly of HCcAg molecules into VLPs during protein purification. In brief, the HCcAg protein was precipitated from yeast cell lysates with ammonium sulfate and renatured by gel filtration on Sephadex G-25 under reducing conditions. VLPs were self-assembled after the removal of the reducing agent by gel filtration on Sephadex G-25. Protein purity and specificity were evaluated by SDS-PAGE and immunoblotting analysis. The molecular mass of VLPs and their relative quantity were measured by HPLC, followed by confirmation of VLPs production and estimation of their shape and size by transmission electron microscopy. As a result, we obtained recombinant HCcAg preparation (with similar to 90% purity) in the form of VLPs and monomers, which has been used to produce hybridomas secreting monoclonal antibodies (mAbs) against HCcAg.
引用
收藏
页数:8
相关论文
共 32 条
  • [21] Hepatitis C virus: Morphogenesis, infection and therapy
    Morozov, Vladimir Alexei
    Lagaye, Sylvie
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (02) : 186 - 212
  • [22] Synergistic effects in antigen capture ELISA using three monoclonal antibodies directed at different epitopes of the same antigen
    Nikulina, VA
    Kizim, EA
    Massino, YS
    Segal, OL
    Smirnova, MB
    Avilov, VV
    Saprigin, DB
    Smotrov, SP
    Tichtchenko, VA
    Kolyaskina, GI
    Dmitriev, AD
    [J]. CLINICA CHIMICA ACTA, 2000, 299 (1-2) : 25 - 44
  • [23] Nooralabettu KP., 2014, Int J Anal Bio-Science Homog, V2, P7
  • [24] Polyak S.J., 2006, Hepatitis C Viruses: Genomes and Molecular Biology
  • [25] Virus-Like Particles as an Instrument of Vaccine Production
    Syomin, B. V.
    Ilyin, Y. V.
    [J]. MOLECULAR BIOLOGY, 2019, 53 (03) : 323 - 334
  • [26] EMAN2: An extensible image processing suite for electron microscopy
    Tang, Guang
    Peng, Liwei
    Baldwin, Philip R.
    Mann, Deepinder S.
    Jiang, Wen
    Rees, Ian
    Ludtke, Steven J.
    [J]. JOURNAL OF STRUCTURAL BIOLOGY, 2007, 157 (01) : 38 - 46
  • [28] The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
    Torresi, Joseph
    [J]. FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [29] Wingfield P., 1998, CURRENT PROTOCOLS A, V53, DOI DOI 10.1002/0471140864.PSA03FS13
  • [30] Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family
    Wong, Shu Hui
    Jassey, Alagie
    Wang, Jonathan Y.
    Wang, Wei-Cheng
    Liu, Ching-Hsuan
    Lin, Liang-Tzung
    [J]. VACCINES, 2019, 7 (04)